DRG, founded in 1970, is a multinational specialty medical equipment and diagnostics manufacturer and distributor, with successful representation in over 110 countries through a network of DRG Subsidiaries and local distributors.
The German division, DRG Instruments GmbH, founded in 1973, is located in Marburg and specializes in the development and production of innovative ELISAS and Chemiluminescent assays, both for routine and research applications, in the fields of diabetes diagnosis, endocrinology, prenatal/neonatal supervision, thyroid function and many more.
In 2013 DRG finished the development of a closed system, our DRG:HYBRiD-XL, a fully automated analyzer for the simultaneous determination of immunoassays, as well as clinical chemistry.
Dihydrotestosterone (DHT-optimized) and Hepcidin 25 (bioactive) HS
NEW: DRG:HYBRiD-XL - Fully Automated Combi Analyzer for Immunoassays and Clinical Chemistry including an interesting test panel: 25-OH Vitamin D, Hepcidin-25, Renin, Aldosterone, Free Testosterone, 17-OH Progesterone, Androstenedione, DHEA, DHEA-S, Calprotectin, anti-CCP, TM-CA72-4, Anti-DGP (Gliadin), Toxoplasma, Cystatin C, HbA1c, Insulin, D-dimer and more.
2014 DRG´s Fully Automated Combi Analyzer has been selected as the Bronze Winner in the "In Vitro Diagnostic Products and Systems" category of the 2014 Medical Design Excellence Awards competition.
In 2015 the analyzer DRG:HYBRID-XL has been nominated for the participation at the German Design Award 2016 - Excellent Product Design in the area of Medical, Rehabilitation and Health Care.